Fortis Therapeutics vs Poseida Therapeutics, Inc.
Fortis Therapeutics
Pioneering antibody-drug conjugate therapies to combat late-stage multiple myeloma and prostate cancer
est. 2016
Poseida Therapeutics, Inc.
A Member of the Roche Group
81 employees · est. 2014 · San Diego, United States
Poseida Therapeutics, Inc. is the older company (2016 vs 2014).
Side-by-Side Comparison
| Metric | Fortis Therapeutics | Poseida Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2014 older |
| Headquarters | ||
| Headquarters | Not tracked yet | San Diego, United States |
| Employees | ||
| Employees | Not tracked yet | 81 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Acquired |
| Total Funding | ||
| Total Funding | $58.00M | $1.88B |
| Funding Rounds | ||
| Funding Rounds | 2 | 9 |
| Services | ||
| Services | Not tracked yet | Cell Therapy Development, Molecule Development, Patient Support Services, Clinical Trials Management, Scientific Research and Publications |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients, Medical Professionals, Pharmaceutical Partners, Scientists, Healthcare Media |
| Taxonomy | ||
| Taxonomy | Immuno-oncologyBiotechAntibody-drug ConjugateCD46Multiple MyelomaProstate Cancer +4 | Allogeneic Cell TherapiesGenetic MedicinesGenome EngineeringCAR-T ProductsGene EditingNon-viral DNA Delivery +9 |
| Website | ||
| Website | fortistx.com | poseida.com |
About Fortis Therapeutics
Fortis Therapeutics is a pioneering immuno-oncology biotech startup founded in 2016. The company's focus lies in developing revolutionary antibody-drug conjugate therapies that target CD46, particularly for combating late-stage multiple myeloma and late-stage prostate cancer, as well as other indica...
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., now a Member of the Roche Group, is a clinical-stage biopharmaceutical company based in the United States. Initially founded in 2014, Poseida was acquired by Roche in early 2025, reinforcing its position in the biopharma and biotechnology industries. Pioneering in alloge...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Fortis Therapeutics and Poseida Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Fortis Therapeutics or Poseida Therapeutics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Fortis Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Fortis Therapeutics on 12 Sep 2024, and Poseida Therapeutics, Inc. on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
